Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estracyt--clinical experiences

T Nilsson

    Scandinavian Journal of Urology and Nephrology. Supplementum
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Estrogen therapy was standard for prostate cancer until new cytotoxic agents emerged. Promising preliminary results suggest chemotherapy may offer cures, especially in early-stage prostate cancer, but more research is needed.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Predicting complications in emergency department patients with acute coronary syndrome - Existing risk scores versus a new logistic regression model.

    American heart journal plus : cardiology research and practice·2026
    Same author

    The practical goals of inpatient forensic mental health services in Sweden - A qualitative comparative analysis of met and unmet rehabilitative needs in the transition to outpatient care.

    International journal of law and psychiatry·2025
    Same author

    Magicity versus Superfluidity around ^{28}O viewed from the Study of ^{30}F.

    Physical review letters·2024
    Same author

    Publisher Correction: First observation of <sup>28</sup>O.

    Nature·2023
    Same author

    First observation of <sup>28</sup>O.

    Nature·2023
    Same author

    Observation of a correlated free four-neutron system.

    Nature·2022
    Same journal

    Bladder cancer-from pathogenesis to prevention, 2008. Proceedings of an international consultation organized by the WHO Collaborating Center for Urologic Tumors. April 24-25, 2008. Stockholm, Sweden.

    Scandinavian journal of urology and nephrology. Supplementum·2009
    Same journal

    The global burden of urinary bladder cancer.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    Same journal

    Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    Same journal

    Screening for bladder cancer: theoretical and practical issues in considering the treated and untreated natural history of the various forms of the disease.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    Same journal

    Combining a molecular profile with a clinical and pathological profile: biostatistical considerations.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    Same journal

    How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.

    Scandinavian journal of urology and nephrology. Supplementum·2008
    See all related articles

    Area of Science:

    • Oncology
    • Urology
    • Medical Treatment

    Background:

    • Estrogen treatment has been the primary therapy for prostate cancer since 1941.
    • Recent advancements include the use of conventional cytotoxic compounds and hormone cytotoxic agents.
    • Preliminary findings from new treatments are highly promising for prostate cancer management.

    Purpose of the Study:

    • To evaluate the efficacy of novel chemotherapy agents in treating prostate cancer.
    • To explore the potential of combined treatment modalities for curative outcomes in prostate cancer.
    • To determine the role of early-stage intervention in improving prostate cancer treatment success.

    Main Methods:

    • Review of preliminary results from studies using cytotoxic compounds and hormone cytotoxic agents.

    Related Experiment Videos

  • Emphasis on the need for controlled randomized trials to validate new treatment approaches.
  • Exploration of chemotherapy's role beyond palliation in advanced prostate cancer.

    • Main Results:

    • Preliminary results of new cytotoxic and hormone cytotoxic agents are very promising.
    • Current chemotherapy use is primarily for palliation in prostate cancer.
    • New treatment strategies and combined modalities show potential for improved outcomes.

    Conclusions:

    • Controlled randomized studies are essential to establish definitive treatment protocols for prostate cancer.
    • Chemotherapy, especially in early stages and in combination therapies, may offer a potential cure for prostate cancer.
    • Further research is required to confirm the curative potential of novel treatment approaches.